43 results
8-K
EX-99.1
f1hwf
6 Dec 22
Regulation FD Disclosure
8:01am
DEF 14A
ebou9eov s5u
2 Sep 22
Definitive proxy
8:30am
S-3
EX-4.8
iq5yal
5 Aug 22
Shelf registration
5:08pm
S-3
bqoo15
5 Aug 22
Shelf registration
5:08pm
S-3
EX-4.9
pehv6if hl45u9fcr4
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
rywg63e3xx9l405 ke
6 Jun 22
Regulation FD Disclosure
8:37am
8-K
EX-99.1
2n7 nbik5lj5
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm
10-K
EX-10.11
ps6lz
29 Mar 22
Annual report
8:46am